Nrx Pharmaceuticals Stock Price on November 7, 2024
| NRXPW Stock | USD 0.07 0.03 30.00% |
Below is the normalized historical share price chart for NRx Pharmaceuticals extending back to December 01, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NRx Pharmaceuticals stands at 0.07, as last reported on the 29th of December, with the highest price reaching 0.1 and the lowest price hitting 0.07 during the day.
If you're considering investing in NRx Stock, it is important to understand the factors that can impact its price. NRx Pharmaceuticals is out of control given 3 months investment horizon. NRx Pharmaceuticals has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.79% are justified by taking the suggested risk. Use NRx Pharmaceuticals Downside Deviation of 17.42, mean deviation of 9.73, and Risk Adjusted Performance of 0.075 to evaluate company specific risk that cannot be diversified away.
Other Stockholder Equity is likely to climb to about 253.4 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (11.1 M). . Price Earnings Ratio is likely to climb to -1.1 in 2024. Price Book Value Ratio is likely to climb to -2.82 in 2024. NRx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of December 2017 | Beta 1.271 |
NRx |
Sharpe Ratio = 0.1262
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NRXPW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 14.21 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.79 actual daily | 35 65% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average NRx Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NRx Pharmaceuticals by adding it to a well-diversified portfolio.
Book Value (1.42) | Shares Float 7.9 M | Market Capitalization 714.6 M | Shares Short Prior Month 3.9 K | Earnings Share (6.25) |
Related Headline
NRX Pharmaceuticals Headline on 7th of November 2024
NRx Pharmaceuticals, Inc. to Report Third Quarter and Year t... by finance.yahoo.com
NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it will release its third quarter and year to date 2024 financial results after the market closes on Thursday, November 14, 2024, via press release, which will be available on the Companys website at httpsir.nrxpharma.com. The Company will host a conference call to discuss the financial results as well as provide a corporate update at 430pm ET th
NRx Pharmaceuticals Valuation on November 7, 2024
It is possible to determine the worth of NRx Pharmaceuticals on a given historical date. On November 7, 2024 NRx was worth 0.0752 at the beginning of the trading date compared to the closed value of 0.076. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NRx Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find NRx Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NRx Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NRx Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.07 | 0.07 | 0.06 | 0.07 | 669.00 | |
11/07/2024 | 0.08 | 0.08 | 0.08 | 0.08 | 959.00 |
| 0.06 | 0.08 | 0.06 | 0.08 | 2,425 |
| Backtest NRx Pharmaceuticals | | | NRx Pharmaceuticals History | | | NRx Pharmaceuticals Valuation | Previous | Next |
NRx Pharmaceuticals Trading Date Momentum on November 7, 2024
| On November 08 2024 NRx Pharmaceuticals was traded for 0.08 at the closing time. The highest daily price throughout the period was 0.08 and the lowest price was 0.06 . The daily volume was 2.4 K. The net trading volume on 11/08/2024 added to the next day price increase. The trading delta at closing time to closing price of the next trading day was 1.32% . The trading delta at closing time to current closing price is 14.47% . |
NRx Pharmaceuticals Fundamentals Correlations and Trends
By evaluating NRx Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NRx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NRx Pharmaceuticals Stock history
NRx Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NRx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NRx Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NRx Pharmaceuticals stock prices may prove useful in developing a viable investing in NRx Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 7.6 M | 7.2 M | |
| Net Loss | -980.6 K | -1 M |
NRx Pharmaceuticals Stock Technical Analysis
NRx Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NRx Pharmaceuticals Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
NRx Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NRx Pharmaceuticals December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how NRx Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NRx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NRx Pharmaceuticals stock market strength indicators, traders can identify NRx Pharmaceuticals entry and exit signals to maximize returns
NRx Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NRx Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NRx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NRx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.075 | |||
| Jensen Alpha | 1.17 | |||
| Total Risk Alpha | 0.7484 | |||
| Sortino Ratio | 0.064 | |||
| Treynor Ratio | (0.73) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.